Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
暂无分享,去创建一个
Y. Horiguchi | J. Nakashima | M. Tachibana | T. Gondo | K. Namiki | M. Ohori | Y. Ohno | K. Yoshioka | T. Hatano | Ozu Choichiro | Tatsuo Gondo
[1] J. Nakashima,et al. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. , 2010, The Journal of urology.
[2] Sanjay G. Patel,et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. , 2010, The Journal of urology.
[3] A. Nicholson,et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.
[4] T. Guzzo,et al. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. , 2008, Urology.
[5] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[6] H. Malik,et al. Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma , 2008, World Journal of Surgery.
[7] Sung Hoon Kim,et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.
[8] Shigemi Matsumoto,et al. The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.
[9] P. Carroll,et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. , 2007, The Journal of urology.
[10] R. Kuefer,et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. , 2007, European urology.
[11] D. Bajorin,et al. Defining optimal therapy for muscle invasive bladder cancer. , 2007, The Journal of urology.
[12] M. Benson,et al. Muscle-invasive urothelial carcinoma of the bladder. , 2007, Urology.
[13] Y. Lotan,et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. , 2006, European urology.
[14] J. Bartlett,et al. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder , 2006, British Journal of Cancer.
[15] C. Dinney. Therapy of invasive bladder cancer. , 2006, Urology.
[16] E. Kikuchi,et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, The Journal of urology.
[17] M. ChB.,et al. Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.
[18] C. Vale. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .
[19] G. Hospers,et al. Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.
[20] Nicholas J Vogelzang,et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.
[21] P. Royston,et al. Metastatic renal carcinoma comprehensive prognostic system , 2003, British Journal of Cancer.
[22] R. Záhorec. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.
[23] D. Bostwick,et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy , 2000, Cancer.
[24] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[25] T. Nishi,et al. Autocrine Growth of Transitional Cell Carcinoma of the Bladder Induced by Granulocyte-Colony Stimulating Factor 1 , 2006 .
[26] R. Dodge,et al. Clinical variables which serve as predictors of cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate , 1994, Cancer.